MedPath

Homeopathic treatment of foot pain

Phase 3
Completed
Conditions
Plantar fascial fibromatosis,
Registration Number
CTRI/2018/10/016014
Lead Sponsor
Mahesh Bhattacharyya Homoeopathic Medical College and Hospital
Brief Summary

Plantar fasciitis affects millions of Americans every or 10 percent ofthe population of the United States. Economic costs from third-party payers relating to the treatment ofplantar fasciitis have been estimated to range from $192 to $376 million peryear. Recent findings suggest plantar fasciitis be a chronic degenerationcausing marked thickening and fibrosis of the plantar fascia along withcollagen necrosis, chondroid metaplasia, and calcification. Little convincing evidence are there to support various approaches for treatingplantar fasciitis including homeopathy. This trial is aimed at exploring the efficacy of individualised homeopathic medicines against placebo in treatment of plantar fasciitis. In this prospective, doubleblind, randomised, placebo controlled, parallel arm trial at MaheshBhattacharyya Homoeopathic Medical College and Hospital, 128 patients sufferingfrom plantar fasciitis will be randomised in 1:1 ratio into either individualisedhomeopathic medicines or identical placebo. Foot Function Index (FFI) will be used as the outcome measure, measured at baseline, and everymonth up to 3 months. At the end of 3 months, comparative analysis will becarried out to detect group differences, if any. Results will be published inscientific journals.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
128
Inclusion Criteria

a) Cases suffering from Plantar fascitis (ICD10 code M72.2) b) Age 18-65 yrs c) Both sexes d) Literate patients; ability to read Bengali and/or English and capability and willingness to give informed consent and to comply with the study procedure.

Exclusion Criteria

a) Cases too sick for consultation b) Cases unwilling to stay after the doctor’s visit c) Patients unable to read patient information sheet d) Patients unwilling to take part or not giving consent to join the study e) Cases suffering from calcaneal spur or some bony deformities or foot pathology f) Diagnosed cases of uncontrolled systemic diseases, unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure g) Patient with psychiatric disorders h) Undergoing homoeopathic treatment for chronic disease within last 6 months i) Self-reported immune-compromised state j) Substance abuse and/or dependence k) Pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Foot Function Index (FFI) questionnaireAt baseline, every month up to 3 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

M. B. Homoeopathic Medical College & Hospital

🇮🇳

Haora, WEST BENGAL, India

M. B. Homoeopathic Medical College & Hospital
🇮🇳Haora, WEST BENGAL, India
Sana Shahid
Principal investigator
8478980104
drsanashahid1503@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.